The following represents disclosure information provided by authors of this abstract. ASCO's Quality Care Symposium Planning Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A quality improvement program to increase performance with clinical oncology pathways.
Janet L. Espirito
No relevant relationships to disclose
Aimee Arlen
No relevant relationships to disclose
Jody S. Garey
No relevant relationships to disclose
Sheetal Sheth
No relevant relationships to disclose
Brian Turnwald
No relevant relationships to disclose
Matthew Clayton
No relevant relationships to disclose
Jennifer Flinn
No relevant relationships to disclose
Carla Butler-Dorian
No relevant relationships to disclose
Greg C. Nelson
No relevant relationships to disclose
J. Russell Hoverman
Employment or Leadership Position - Texas Oncology; The US Oncology Network
Consultant or Advisory Role - United Health Care
Debra A. Patt
No relevant relationships to disclose
Thomas H. Cartwright
Consultant or Advisory Role - Amgen; Genentech; Lilly; Sanofi
Honoraria - Amgen; Lilly; Roche; Sanofi
Leslie T. Busby
No relevant relationships to disclose
Roy A. Beveridge
No relevant relationships to disclose
Marcus A. Neubauer
No relevant relationships to disclose